Showing results (701-710 of 1,516) with videos related to
Sort By:
Pageof 152
BMJ Open|July 22, 2020
Qualitative study to explore radiologist and radiologic technologist perceptions of outcomes patients experience during imaging in the USAMonica Zigman Suchsland, Maria Jessica Cruz, Victoria Hardy, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2019
Long-Term Outcomes of HIV-Infected Women Receiving Antiretroviral Therapy After Transferring Out of an Integrated Maternal and Child Health Service in South AfricaTamsin K Phillips, Pheposadi Mogoba, Kirsty Brittain, et al.Future Neurology|January 12, 2013
Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disordersRajesh Khanna, Sarah M Wilson, Joel M Brittain, et al.Experimental Neurology|May 29, 2012
Oscillatory activity in the subthalamic nucleus during arm reaching in Parkinson's diseaseRaed A Joundi, John-Stuart Brittain, Alex L Green, et al.Biochemistry|January 26, 2008
Redox-linked structural changes associated with the formation of a catalytically competent form of the diheme cytochrome c peroxidase from Pseudomonas aeruginosaAude Echalier, Thomas Brittain, Joshua Wright, et al.Ophthalmic Plastic and Reconstructive Surgery|July 24, 2012
Indications for orbital decompression for patients undergoing keratoprosthesis surgeryJonathan H Norris, David Carpenter, Nancy Al Raqqad, et al.Frontiers in Medicine|March 7, 2024
Low incidence of malignancy in patients with suspected polymyalgia rheumatica or giant cell arteritis, examined with FDG-PET/CTTanja Fromberg Gorlen, Jane Maestri Brittain, Mikkel Østergaard, et al.BMJ Open|February 1, 2023
Safety and efficacy of an artificial intelligence-enabled decision tool for treatment decisions in neovascular age-related macular degeneration and an exploration of clinical pathway integration and implementation: protocol for a multi-methods validation studyHenry David Jeffry Hogg, Katie Brittain, Dawn Teare, et al.Ophthalmology and Therapy|October 9, 2025
Targeting IL-6 Receptor Signaling with Satralizumab in Thyroid Eye Disease: Design of the Phase 3 SatraGO-1 and SatraGO-2 TrialsDaniel Ezra, Atif Collins, Zdenka Haskova, et al.Journal of Human Hypertension|July 5, 2023
Urban-rural differences in hypertension prevalence, blood pressure control, and systolic blood pressure levelsBrittain Heindl, George Howard, Stephen Clarkson, et al.Pageof 152